Market News & Trends
PromoCell Now Offers In Vitro Disease Models That Could Lead to New Therapies
PromoCell now offers cell disease models covering a wide range of diseases, including diabetes type 1 and 2, respiratory diseases, such as COPD and asthma,…
New Study From Tufts Center for the Study of Drug Development Establishes Benchmarks
While more than 90% of all contract vendor assessments conducted by drug sponsors ultimately lead to vendors being qualified to provide services, large sponsors have…
Centogene Signs Collaboration Agreement With Pfizer
CENTOGENE recently announced a new data access and collaboration agreement with Pfizer Inc. The agreement grants Pfizer access to CENTOGENE’s data repository, which may be…
Aravive & AstraZeneca Announce Initiation of Randomized Phase 1/2 Study
Aravive, Inc. and AstraZeneca recently announced that an investigator-sponsored Phase 1/2 clinical trial of AVB-500, a GAS6/AXL inhibitor, in combination with durvalumab, a PD-L1 inhibitor,…
Vetter’s US Site Offers Clinical Manufacturing for Successful Drug Development of Injectables
Pharma and biotech companies, both large and small, have high expectations for their new molecules they have in development. Even the smallest of details can impact the eventual success or failure of their product…..
NervGen Pharma Expands Platform Into Alzheimer's Disease
NervGen Pharma Corp. recently announced a research initiative to advance its proprietary therapeutic technology platform, currently in development for spinal cord injury and multiple sclerosis,…
Aptar Acquires Noble International, a Leader in Drug Delivery Training Devices & Patient Onboarding
AptarGroup, Inc. recently announced it has acquired Noble International, a leader in drug delivery training devices and patient onboarding. This acquisition furthers Aptar’s strategy to broaden……
Flexion Announces Clearance of NDA for Gene Therapy Candidate
Flexion Therapeutics, Inc. recently announced clearance of the company’s Investigational New Drug (IND) application for FX201 in knee osteoarthritis.
Cycle Pharmaceuticals & Catalent Partner to Develop Treatments for Rare Diseases
Cycle Pharmaceuticals Ltd. has recently signed an agreement with Catalent, Inc. to develop innovative formulations targeting rare disease patients.
Ashland Launches New Excipient Solutions for Improved Drug Delivery
Ashland recently announced the launch of three new pharmaceutical solutions, Plasdone S630 Ultra, Benecel XR and XRF, and Viatel bioresorbable polymers. Ashland is expanding its portfolio to meet formulators’ growing needs….
Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials
Menlo Therapeutics Inc. recently announced it has completed enrollment of patients in its two Phase 3 clinical trials evaluating the safety and efficacy of once-daily…
Artelo Biosciences Announces Selection of Clinical Research Organization
Artelo Biosciences, Inc. recently announced it has selected Aptus Clinical Ltd. (Aptus) as its contract research organization (CRO) for the company’s planned Phase 1b/2a randomized,…
Disc Medicine Completes $50-Million Series A Financing, Enters Exclusive License Agreement With AbbVie
Disc Medicine recently announced the completion of a $50-million Series A financing. The company’s novel approach focuses on targeting hepcidin, a key regulator of iron…
Femtogenix Presents Novel Data on Antibody Drug Conjugates
Femtogenix Ltd recently announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine (PDD) ADC payload platform…
Octapharma Adopts Genedata Bioprocess to Develop Next-Generation Bio-Manufacturing Processes
Genedata recently announced that Octapharma has adopted the Genedata Bioprocess platform to support the development and manufacturing of therapeutic proteins addressing severe diseases in the…
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-Focused Emerald Organic Products
Amarantus will receive Emerald Preferred Stock to be valued at a minimum of $100 million in 2022, and up to double digit royalties (in addition to pass-through royalties and milestones) in exchange for worldwide, exclusive development and commercial rights to….
Sustainability is Everyone’s Obligation
Acting with social responsibility is far more than the very important role of environment protection, it also includes overall sustainability and acting in a manner that…..
Nanotechnology World Association is Launched by Solid Group of Founding Members
This new global nanotechnology association will bolster the necessary links between research and industries and facilitate the adoption and commercialization of…….
Driving Improvements in Clinical Trial Results Sharing
The world’s leading medical journals now require authors to disclose whether or not they’ll be sharing clinical trial results, a public declaration that may nudge…
CPI Accelerates Gene Therapy Development With Robust Purification System
CPI recently announced the success of its CRD IUK project to develop a scalable, cost-effective purification process for adeno-associated viruses (AAVs), in partnership with Cobra…
